Search research articles
Contact Us
Filters
Showing results (171-180 of 190) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2021
<i>TP53</i> Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic Leukemia
Riccardo Bomben, Francesca Maria Rossi, Filippo Vit, et al.
Leukemia
|
August 14, 2024
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands
Erika Tissino, Annalisa Gaglio, Antonella Nicolò, et al.
Blood
|
March 6, 2026
CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL
Laura Polcik, Abhishek Pethe, Driti Ashok, et al.
Blood
|
May 29, 2026
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas
Alberto J Arribas, Eleonora Cannas, Giulio Sartori, et al.
Blood
|
December 1, 2010
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome
Andrea Rinaldi, Michael Mian, Ekaterina Chigrinova, et al.
British Journal of Haematology
|
August 15, 2023
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling
Riccardo Moia, Lodovico Terzi di Bergamo, Donatella Talotta, et al.
Blood
|
September 6, 2013
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
Ekaterina Chigrinova, Andrea Rinaldi, Ivo Kwee, et al.
The Journal of Experimental Medicine
|
August 15, 2012
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development
Davide Rossi, Vladimir Trifonov, Marco Fangazio, et al.
Leukemia
|
June 18, 2025
Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia
Filippo Vit, Tamara Bittolo, Antonella Zucchetto, et al.
Leukemia
|
July 8, 2025
Integration of [<sup>18</sup>F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma
Riccardo Dondolin, Federico Garrou, Mohammad Almasri, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 190) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 21, 2021
<i>TP53</i> Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic Leukemia
Riccardo Bomben, Francesca Maria Rossi, Filippo Vit, et al.
Leukemia
|
August 14, 2024
The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands
Erika Tissino, Annalisa Gaglio, Antonella Nicolò, et al.
Blood
|
March 6, 2026
CD49d governs immune synapse formation through actin rearrangements and synchronizes BCR signaling in CLL
Laura Polcik, Abhishek Pethe, Driti Ashok, et al.
Blood
|
May 29, 2026
IL-16 production is a mechanism of resistance to BTK inhibitors and R-CHOP in lymphomas
Alberto J Arribas, Eleonora Cannas, Giulio Sartori, et al.
Blood
|
December 1, 2010
Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome
Andrea Rinaldi, Michael Mian, Ekaterina Chigrinova, et al.
British Journal of Haematology
|
August 15, 2023
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling
Riccardo Moia, Lodovico Terzi di Bergamo, Donatella Talotta, et al.
Blood
|
September 6, 2013
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
Ekaterina Chigrinova, Andrea Rinaldi, Ivo Kwee, et al.
The Journal of Experimental Medicine
|
August 15, 2012
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development
Davide Rossi, Vladimir Trifonov, Marco Fangazio, et al.
Leukemia
|
June 18, 2025
Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemia
Filippo Vit, Tamara Bittolo, Antonella Zucchetto, et al.
Leukemia
|
July 8, 2025
Integration of [<sup>18</sup>F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma
Riccardo Dondolin, Federico Garrou, Mohammad Almasri, et al.
Page
of 19